Oric Pharmaceuticals Inc. (ORIC): Price and Financial Metrics


Oric Pharmaceuticals Inc. (ORIC): $3.56

0.38 (+11.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORIC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ORIC Stock Price Chart Interactive Chart >

Price chart for ORIC

ORIC Price/Volume Stats

Current price $3.56 52-week high $26.70
Prev. close $3.18 52-week low $2.62
Day low $3.09 Volume 319,500
Day high $3.58 Avg. volume 505,722
50-day MA $4.23 Dividend yield N/A
200-day MA $12.37 Market Cap 140.54M

Oric Pharmaceuticals Inc. (ORIC) Company Bio


Oric Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.


ORIC Latest News Stream


Event/Time News Detail
Loading, please wait...

ORIC Latest Social Stream


Loading social stream, please wait...

View Full ORIC Social Stream

Latest ORIC News From Around the Web

Below are the latest news stories about Oric Pharmaceuticals Inc that investors may wish to consider to help them evaluate ORIC as an investment opportunity.

2 Falling Knives to Catch

ORIC Pharmaceuticals Inc. and Ondas Holdings Inc. have positive ratings despite falling more than 59% over the past year

Yahoo | February 22, 2022

ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a virtual fireside chat at the Guggenheim 2022 Oncology Conference on Thursday, February 10, 2022, at 2:00 p.m. ET. A live webcast of the fireside chat will be available through the investor section of the comp

Yahoo | February 2, 2022

Emerald Advisers, Llc Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals ...

Investment company Emerald Advisers, Llc (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, HireRight Holdings Corp, Arhaus Inc, sells Chegg Inc, ORIC Pharmaceuticals Inc, BellRing Brands Inc, Trex Co Inc, Arena Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Advisers, Llc.

Yahoo | February 2, 2022

Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ...

Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust.

Yahoo | February 2, 2022

Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Yahoo | February 1, 2022

Read More 'ORIC' Stories Here

ORIC Price Returns

1-mo -2.20%
3-mo -56.16%
6-mo -73.57%
1-year -84.42%
3-year N/A
5-year N/A
YTD -75.78%
2021 -56.57%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5448 seconds.